Below are your results for the search term: nhl or lymphoma
Search Again Back to previous page
- 1. The Emerging Cancer Vaccine Market
- 2. Therapeutic Proteins
- 3. The World Market for In Vitro Diagnostics, 2005
- 4. Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- 5. Pipeline Insight: Multiple Sclerosis - The oral revolution
- 6. Therapeutic Cancer Vaccines - A turbulent path from bench to bedside
- 7. Pricing and Reimbursement in Oncology
- 8. Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- 9. Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- 10. Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
- 11. Preclinical Cancer Therapeutics 2007
- 12. Chemotherapy Market Insights, 2006-2016
- 13. Therapeutic Vaccines
- 14. Innovative Targeted Oncology Therapies
- 15. Lifecycle Management: Accessing New Patient Populations - Maximizing ROI of Indication Management
- 16. Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to Success
- 17. Pipeline Insight: Hematological malignancies - Targeted treatments & immunotherapy
- 18. Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
- 19. Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- 20. NON - HODGKIN LYMPHOMA (NHL) - Therapy Area Pipeline Report
- 21. Pipeline Insight: Molecular Targeted Cancer Therapies
- 22. Histone deacetylase inhibitors
- 23. BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- 24. Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success?
- 25. Favrille Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
- 26. Cougar Biotechnology Inc: Company Profile
- 27. Allos Therapeutics Inc: Premium Company Profile
- 28. Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbust
- 29. Millennium Pharmaceuticals Inc: Premium Company Profile
- 30. Cancer Therapeutics - Market Insight and R&D Pipeline Analysis
- 31. Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis
- 32. Pipeline Insight: Molecular Targeted Cancer Therapies - More pipeline activity, less product differentiation
- 33. Cancer Therapeutics: Market Insight and R&D Pipeline Analysis
- 34. Non-Hodgkin's Lymphomas Diffuse large B-cell lymphoma and follicular lymphoma
- 35. The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- 36. Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
1 - 36 results